Osimertinib is associated with improved outcomes in pre-treated non-small cell lung cancer leptomeningeal metastases: A systematic review and meta-analysiss
Article in Heliyon (April 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Heliyon (April 2024)
Article in Current Cancer Drug Targets (January 2024)
Article in Frontiers in Oncology (October 2023)